Corporate News 04-Feb-19
Laurus Labs receves USFDA tentative approval for PEPFAR for TLD FDC
Laurus Labs has received tentative approval from United States Food and Drug Administration (US FDA) under PEPFAR for Tenofovir/Lamivudine/Dolutegravir (TLD) 300/300/50mg fixed dose combination (FDC).
Previous News
Laurus Labs Ltd soars 2.21%, Gains for third straight session
( Hot Pursuit - 30-Jul-24 13:05 )
Laurus Labs Ltd rises for third consecutive session
( Hot Pursuit - 02-Apr-24 13:05 )
Laurus Labs Ltd spurts 0.92%, rises for fifth straight session
( Hot Pursuit - 11-Oct-23 13:00 )
Laurus Labs allots 2.83 lakh equity shares under ESOS
( Corporate News - 09-Dec-23 12:09 )
Laurus Labs Hyderabad unit clears USFDA inspection
( Hot Pursuit - 14-Sep-24 16:55 )
Laurus Labs consolidated net profit declines 55.32% in the March 2023 quarter
( Results - Announcements 27-Apr-23 16:01 )
Laurus Labs Ltd up for third straight session
( Hot Pursuit - 03-May-23 13:05 )
Laurus Labs Unit-2 receives Establishment Inspection Report
( Corporate News - 15-Jun-23 16:53 )
Laurus Labs consolidated net profit declines 49.66% in the June 2024 quarter
( Results - Announcements 25-Jul-24 15:23 )
Laurus Labs slips as Q4 PAT slumps 55% YoY; R&D exp at Rs 211 cr in FY23
( Hot Pursuit - 27-Apr-23 15:43 )
Laurus Labs Ltd slips for fifth straight session
( Hot Pursuit - 13-Jul-23 13:35 )
Other Stories
Tata Motors records 12% decline in Q2 sales
01-Oct-24 18:04
Tata Motors records 15% decline in September sales
01-Oct-24 17:55
Man Infra set to launch its highly anticipated Vile Parle project
01-Oct-24 17:48
Padam Cotton Yarns to declare Quarterly Result
01-Oct-24 17:39
Blueblood Ventures schedules board meeting
01-Oct-24 17:39
CRISIL to discuss results
01-Oct-24 17:39
Indian Renewable Energy Deve. Agency to convene board meeting
01-Oct-24 17:39
Ashapuri Gold Ornament schedules board meeting
01-Oct-24 17:38
Bijoy Hans to conduct board meeting
01-Oct-24 17:38
RS Software (India) to announce Quarterly Result
01-Oct-24 17:38
Back
Top
